Search research articles
Contact Us
Filters
Showing results (61-70 of 358) with videos related to
Page
of 36
Sort By:
International Journal of Molecular Sciences
|
November 11, 2022
Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D
Hadil Onallah, Sheethal Thomas Mannully, Ben Davidson, et al.
Virchows Archiv : an International Journal of Pathology
|
June 1, 2023
Correction to: Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Ben Davidson, Delfim Doutel, Arild Holth, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 7, 2024
Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma
Ben Davidson, Tone Skeie-Jensen, Arild Holth, et al.
Diagnostic Cytopathology
|
May 24, 2012
The diagnostic and research applications of flow cytometry in cytopathology
Ben Davidson, Hiep Phuc Dong, Aasmund Berner, et al.
Virchows Archiv : an International Journal of Pathology
|
April 17, 2023
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Ben Davidson, Delfim Doutel, Arild Holth, et al.
International Journal of Molecular Sciences
|
December 4, 2012
Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure
Ilana Weiss, Claes G Trope, Reuven Reich, et al.
Nature Protocols
|
June 13, 2008
Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry
Hiep Phuc Dong, Lilach Kleinberg, Ben Davidson, et al.
Arkhiv Patologii
|
September 2, 2004
The biological role and regulation of matrix metalloproteinases (MMP) in cancer
Ben Davidson, Reuven Reich, Bjørn Risberg, et al.
American Journal of Clinical Pathology
|
January 21, 2012
PRAME (preferentially expressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma
Kjersti Brenne, Dag André Nymoen, Reuven Reich, et al.
Human Pathology
|
May 27, 2018
The diagnostic role of BAP1 in serous effusions
Ben Davidson, Martin Tötsch, Jeremias Wohlschlaeger, et al.
Page
of 36
Search research articles
Search
Showing results (61-70 of 358) with videos related to
Sort By:
Page
of 36
International Journal of Molecular Sciences
|
November 11, 2022
Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D
Hadil Onallah, Sheethal Thomas Mannully, Ben Davidson, et al.
Virchows Archiv : an International Journal of Pathology
|
June 1, 2023
Correction to: Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Ben Davidson, Delfim Doutel, Arild Holth, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 7, 2024
Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma
Ben Davidson, Tone Skeie-Jensen, Arild Holth, et al.
Diagnostic Cytopathology
|
May 24, 2012
The diagnostic and research applications of flow cytometry in cytopathology
Ben Davidson, Hiep Phuc Dong, Aasmund Berner, et al.
Virchows Archiv : an International Journal of Pathology
|
April 17, 2023
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Ben Davidson, Delfim Doutel, Arild Holth, et al.
International Journal of Molecular Sciences
|
December 4, 2012
Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure
Ilana Weiss, Claes G Trope, Reuven Reich, et al.
Nature Protocols
|
June 13, 2008
Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry
Hiep Phuc Dong, Lilach Kleinberg, Ben Davidson, et al.
Arkhiv Patologii
|
September 2, 2004
The biological role and regulation of matrix metalloproteinases (MMP) in cancer
Ben Davidson, Reuven Reich, Bjørn Risberg, et al.
American Journal of Clinical Pathology
|
January 21, 2012
PRAME (preferentially expressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma
Kjersti Brenne, Dag André Nymoen, Reuven Reich, et al.
Human Pathology
|
May 27, 2018
The diagnostic role of BAP1 in serous effusions
Ben Davidson, Martin Tötsch, Jeremias Wohlschlaeger, et al.
Page
of 36